Duke University Health System
Durham, North Carolina, 27710, United States
NCT Number: NCT05328713
The purpose of this study is to determine the occurrence of scarring of the heart (cardiac fibrosis) and inflammation in those with perinatally acquired Human Immunodeficiency Virus (HIV) infection compared to people not infected with HIV. The information learned from this research may help the investigator to better understand the link between cardiac fibrosis and cardiac dysfunction and inflammation in those with perinatally acquired HIV infection compared to the uninfected.
Participants will have a blood sample, complete a patient questionnaire, and have a Magnetic resonance imaging (MRI) and ultrasound of the heart.
Researchers will review the medical record and past medical history, for information about your heart function and overall health. Research samples and data from this study will be stored indefinitely and used for other research.
There are risks to participate in this study and those risks include side effects from the contrast agent used for the MRI scan, (such as headache and injection site pain), and risks from blood sampling.
Looking for future studies?
Notify Me20 year–45 year
All sexes
Observational
Durham, North Carolina, 27710, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This study will use Cardiac MRI to identify subclinical cardiac dysfunction.
Time frame: Baseline Visit
Compare myocardial fibrosis for HIV+ and control subjects (unit = percentage)
Time frame: Baseline Visit
Compare Left ventricular ejection fraction (LVEF) for HIV+ and control subjects (unit = percentage) Compare left ventricle (LV) mass for HIV+ and control subjects (unit = grams)
Time frame: Baseline Visit
Compare native T2 mapping values for HIV+ and control subjects (unit = ms)
Time frame: Baseline Visit
Compare native T1 mapping values for HIV+ and control subjects (unit = ms)
Time frame: Baseline Visit
Compare ECV for HIV+ and control subjects (unit=percentage)
Duke University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06340698
HIV, Perinatal HIV Infection
Nanning, Guangxi, China
View Trial DetailsNCT05206123
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Paris, France
View Trial DetailsNCT04206241
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Beitbridge, Zimbabwe
View Trial DetailsNCT02921321
Cardiac Fibrosis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Washington D.C., District of Columbia, United States
View Trial Details